Litigation Details for ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)
✉ Email this page to a colleague
ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-05-15 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-06-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 8,431,154; 8,536,206; 8,604,064; 8,618,142 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ASTRAZENECA AB v. TORRENT PHARMA INC.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-07-13 | 106 | Order | term "roflumilast" as it appears in U.S. Patent Nos. 8,536,206, 8,604,064, and 8,618,142, means "N-(3,5…2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey | External link to document |
| 2016-10-18 | 134 | Opinion | three of the patents involved in this action: U.S. Patent Nos. 8,536,206 (the “‘206 Patent”), 8,604,064…roflumilast. ‘206 Patent at 1:1-17; ‘064 Patent at 1:1-19; ‘142 Patent at 1:1-19; ‘791 Patent at 8:29-20:…roflumilast. ‘206 Patent at 1:4-9; ‘064 Patent at 1:4-13; ‘142 Patent at 1:4-13; ‘791 Patent at 8:29-20:6… ‘791 Patent on November 26, 2008. 206 Patent at 1:4-9; ‘064 Patent at 1:4-13; ‘142 Patent at 1:4-13…8,604,064 (the “‘064 Patent”), and 8,618,142 (the “‘142 Patent”) (collectively, the “Patents-at-Issue”). The | External link to document |
| 2017-06-02 | 181 | Opinion | difluoromethoxybenzamide” in U.S. Patent Nos. 8,536,206 (the “‘206 Patent”), 8,604,064 (the “‘064 Patent”), and 8,618,142…roflumilast. ‘206 Patent at 1:1-17; ‘064 Patent at 1:1-19; ‘142 Patent at 1:1-19; ‘791 Patent at 8:29-20:6…206 Patent at 8:21-10:34; ‘064 Patent at 8:37-10:33; ‘142 Patent at 8:22-9:21. 3 The ‘791 Patent, not…the same family of patents as U.S. Patent No. 7,470,791 (the “‘791 Patent”), which purportedly protects…:6. Both the ‘206 Patent and the ‘064 Patent are process patents that claim methods for the treatment | External link to document |
| 2017-08-31 | 192 | Memorandum | respect to U.S. Patent Nos. 8, 536, 206 (“the ‘206 patent”), 8, 504, 064 (“the ‘064 patent”) and 8, 618,…618, 142 (“the ‘142 patent”) (collectively, “the Patents”) in order to assert invalidity under 35 U.S.C… the named inventor of another asserted patent (U.S. Patent No. 5,712,298), and that none of the named…contention that the Patents “were secured through extensive fraud at the U.S. Patent and Trademark Office…allege unenforceability of three of the asserted patents for inequitable conduct. Plaintiffs have filed | External link to document |
| 2018-02-21 | 231 | Order | Licensed Patents” shall mean United States Patent Numbers 8,604,064, 8,618,142 and 8,536,206; and (…assigns, is enjoined from infringing the Licensed Patents, on its own part or through any Affiliate, …2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey | External link to document |
| 2016-02-22 | 53 | Stipulation and Order | STIPULATION AND CONSENT ORDER re: 8,431,154 patent; the current 3/1/2016 deadline for Takeda and…2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
